Oxford University and AstraZeneca will be sharing their data from phase-I trial of their much-touted Covid-19 vaccine candidate on July 20. There are already indications that the data could turn out to be “positive.”
Search for vaccines hots up as Covid-19 continues to spread and wreak havoc around the world
